(Q42237457)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24521854%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

title

Rilpivirine exposure in plasma and sanctuary site compartments after switching from nevirapine-containing combined antiretroviral therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24521854%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24521854%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Victoria Watson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24521854%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Jaime H Vera

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24521854%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Adam D Waldman

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24521854%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

author name string

Rosy Weston

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24521854%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Steve Kaye

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24521854%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Saye Khoo

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24521854%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Nicola E Mackie

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24521854%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

David Back

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24521854%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Alan Winston

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24521854%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

language of work or name

English

0 references

publication date

11 February 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24521854%20AND%20SRC:MED&resulttype=core&format=json

Journal of Antimicrobial Chemotherapy

7 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24521854%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

volume

69

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24521854%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24521854%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

page(s)

1642-1647

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24521854%20AND%20SRC:MED&resulttype=core&format=json

Pharmacokinetic parameters of once-daily rilpivirine following administration of efavirenz in healthy subjects.

7 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU018

Changing incidence of central nervous system diseases in the EuroSIDA cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU018

Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU018

Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU018

Neurocognitive effects of treatment interruption in stable HIV-positive patients in an observational cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU018

Efficacy of cerebrospinal fluid (CSF)-penetrating antiretroviral drugs against HIV in the neurological compartment: different patterns of phenotypic resistance in CSF and plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU018

Efavirenz concentrations in CSF exceed IC50 for wild-type HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU018

Etravirine concentrations in CSF in HIV-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU018

Raltegravir cerebrospinal fluid concentrations in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU018

Pharmacokinetics of antiretroviral drugs in anatomical sanctuary sites: the male and female genital tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU018

Validation of a rapid and sensitive high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) assay for the simultaneous determination of existing and new antiretroviral compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU018

TMC278, a next-generation nonnucleoside reverse transcriptase inhibitor (NNRTI), active against wild-type and NNRTI-resistant HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU018

Low nevirapine plasma concentrations predict virological failure in an unselected HIV-1-infected population

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU018

High exposure to nevirapine in plasma is associated with an improved virological response in HIV-1-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU018